Fatty acids in serum phospholipids and carotid intima-media thickness in Spanish subjects with primary dyslipidemia

American Journal of Clinical Nutrition

Volumn 92, Issue 1, 2010, Pages 186-193

  Sala Vila, Aleix ^a,b   Cofán, Montserrat ^a,b   Pérez Heras, Ana ^a,b   Núñez, Isabel ^b   Gilabert, Rosa ^a   Junyent, Mireia ^a,b   Mateo Gallego, Rocío ^c   Cenarro, Ana ^c   Civeira, Fernando ^c   Ros, Emilio ^a,b  

^a HOSPITAL CLÍNIC   (Spain)

^b Instituto de Salud Carlos III   (Spain)

^c HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

DOCOSAHEXAENOIC ACID; FATTY ACID; ICOSAPENTAENOIC ACID; LINOLEIC ACID; LINOLENIC ACID; OLEIC ACID; OLIVE OIL; OMEGA 3 FATTY ACID; PHOSPHATIDYLCHOLINE; PHOSPHOLIPID; VEGETABLE OIL; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTERIAL WALL THICKNESS; ARTICLE; CARDIOVASCULAR RISK; CAROTID ARTERY; CAROTID ATHEROSCLEROSIS; COMMON CAROTID ARTERY; CROSS-SECTIONAL STUDY; DIETARY INTAKE; DYSLIPIDEMIA; ECHOGRAPHY; FAT INTAKE; FEMALE; FISH; FOOD INTAKE; HUMAN; ISCHEMIC HEART DISEASE; LIPID COMPOSITION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PHOSPHOLIPID BLOOD LEVEL; SPAIN; ULTRASOUND; WALNUT; BLOOD; BODY MASS; CARDIOVASCULAR DISEASE; FEEDING BEHAVIOR; INTIMA; METABOLISM; MIDDLE AGED; NUT; PATHOLOGY; RISK FACTOR; TUNICA MEDIA;

JUGLANS; PYRULARIA PUBERA;

ADULT; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CAROTID ARTERIES; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CROSS-SECTIONAL STUDIES; DIETARY FATS; DYSLIPIDEMIAS; FATTY ACIDS; FATTY ACIDS, OMEGA-3; FEMALE; FOOD HABITS; HUMANS; LECITHINS; MALE; MIDDLE AGED; NUTS; OLEIC ACIDS; PHOSPHOLIPIDS; RISK FACTORS; SPAIN; TUNICA INTIMA; TUNICA MEDIA;

EID: 77954599598     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.2009.28807     Document Type: Article

References (47)

1. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 2006;367:1747-57.
2. Tunstall-Pedoe H, Kuulasmaa K, Mahonen M, Tolonen H, Ruokoski E, Amouyel P. Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA project populations. Monitoring trends and determinants in cardiovascular disease. Lancet 1999;353:1547-57.
3. Marrugat J, Elosua R, Aldasoro E, et al. Regional variability in population acute myocardial infarction cumulative incidence and mortality rates in Spain 1997 and 1998. Eur J Epidemiol 2004;19:831-9.
4. Gabriel R, Alonso M, Segura A, et al. Prevalence, geographic distribution, and geographic variability of major cardiovascular risk factors in Spain. Pooled analysis of data from population-based epidemiological studies: the ERICE Study. Rev Esp Cardiol 2008;61:1030-40.
5. Wilson PWF, D'Agostino RB, Levy D, et al. Prediction of coronary heart disease using risk factor categories. Circulation 1998;97:1837-47.
6. Marrugat J, d'Agostino R, Sullivan L, et al. An adaptation of the Framingham coronary heart disease risk function to European Mediterranean areas. J Epidemiol Community Health 2003;57:634-8.
7. Sofi F, Cesari F, Abbate R, Gensini GF, Casini A. Adherence to Mediterranean diet and health status: meta-analysis. BMJ 2008;337:a1344 .
8. Linseisen J, Bergström E, Gafá L, et al. Consumption of added fats and oils in the European Prospective Investigation into Cancer and Nutrition (EPIC) centres across 10 European countries as assessed by 24-hour dietary recalls. Public Health Nutr 2002;5:1227-42.
9. Carluccio MA, Massaro M, Scoditti E, De Caterina R. Vasculoprotective potential of olive oil components. Mol Nutr Food Res 2007;51:1225-34. (Pubitemid 350017475)
10. Brown JM, Shelness GS, Rudel LL. Monounsaturated fatty acids and atherosclerosis: opposing views from epidemiology and experimental animal models. Curr Atheroscler Rep 2007;9:494-500.
11. Welch AA, Lund E, Amiano P, et al. Variability of fish consumption within the 10 European countries participating in the European Investigation into Cancer and Nutrition (EPIC) study. Public Health Nutr 2002;5:1273-85.
12. Garcia-Closas R, Berenguer A, González CA. Changes in food supply in Mediterranean countries from 1961 to 2001. Public Health Nutr 2006;9:53-60.
13. Calder PC. n-3 Fatty acids and cardiovascular disease: evidence explained and mechanisms explored. Clin Sci (Lond) 2004;107:1-11.
14. Hino A, Adachi H, Toyomasu K, et al. Very long chain N-3 fatty acids intake and carotid atherosclerosis. An epidemiological study evaluated by ultrasonography. Atherosclerosis 2004;176:145-9.
15. Erkkilä AT, Matthan NR, Herrington DM, Lichtenstein AH. Higher plasma docosahexaenoic acid is associated with reduced progression of coronary atherosclerosis in women with CAD. J Lipid Res 2006;47:2814-9.
16. Mita T, Watada H, Ogihara T, et al. Eicosapentaenoic acid reduces the progression of carotid intima-media thickness in patients with type 2 diabetes. Atherosclerosis 2007;191:162-7.
17. Sekikawa A, Curb JD, Ueshima H, et al. Marine-derived n-3 fatty acids and atherosclerosis in Japanese, Japanese-American, and white men: a cross-sectional study. J Am Coll Cardiol 2008;52:417-24.
18. He K, Liu K, Daviglus ML, et al. Intakes of long-chain n-3 polyunsaturated fatty acids and fish in relation to measurements of subclinical atherosclerosis. Am J Clin Nutr 2008;88:1111-8.
19. de Lorgeril M, Salen P, Martin JL, Monjaud I, Delaye J, Mamelle N. Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study. Circulation 1999;99:779-85.
20. Djoussé L, Folsom AR, Province MA, Hunt SC, Ellison RC. Dietary linolenic acid and carotid atherosclerosis: the National Heart, Lung, and Blood Institute Family Heart Study. Am J Clin Nutr 2003;77:819-25.
21. Djoussé L, Arnett DK, Carr JJ, et al. Dietary linolenic acid is inversely associated with calcified atherosclerotic plaque in the coronary arteries - The National Heart, Lung, and Blood Institute Family Heart Study. Circulation 2005;111:2921-6.
22. Harris WS. Alpha-linolenic acid: a gift from the land? Circulation 2005;111:2872-4.
23. Mozaffarian D, Ascherio A, Hu FB, et al. Interplay between different polyunsaturated fatty acids and risk of coronary heart disease in men. Circulation 2005;111:157-64.
24. Hodson L, Skeaff CM, Fielding BA. Fatty acid composition of adipose tissue and blood in humans and its use as a biomarker of dietary intake. Prog Lipid Res 2008;47:348-80.
25. Harris WS, Poston WC, Haddock CK. Tissue n23 and n26 fatty acids and risk for coronary heart disease events. Atherosclerosis 2007;193:1-10.
26. Lorenz MW, Markus HS, Bots ML, Rosvall M, Sitzer M. Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation 2007;115:459-67.
27. Durrington P. Dyslipidaemia. Lancet 2003;362:717-31.
28. Gómez-Gerique JA, Gutiérrez-Fuentes JA, Montoya MT, et al. Lipid profile of the Spanish population: the DRECE [Diet and Risk of Cardiovascular Disease in Spain] study. DRECE study group. Med Clin (Barc) 1999;113:730-5.
29. Pocovi M, Civeira F, Alonso R, Mata P. Familial hypercholesterolemia in Spain: case-finding program, clinical and genetic aspects. Semin Vasc Med 2004;4:67-74.
30. Tejedor D, Castillo S, Mozas P, et al. Reliable low-density DNA array based on allele-specific probes for detection of 118 mutations causing familial hypercholesterolemia. Clin Chem 2005;51:1137-44.
31. Burdge GC, Wright P, Jones AE, Wootton SA. A method for separation of phosphatidylcholine, triacylglycerol, non-esterified fatty acids and cholesterol esters from plasma by solid-phase extraction. Br J Nutr 2000;84:781-7.
32. Junyent M, Cofán M, Núñez I, Gilabert R, Zambón D, Ros E. Influence of the HDL cholesterol level on preclinical carotid atherosclerosis in familial hypercholesterolemia. Arterioscler Thromb Vasc Biol 2006;26:1107-13.
33. Martin-Moreno JM, Boyle P, Gorgojo L, et al. Development and validation of a food frequency questionnaire in Spain. Int J Epidemiol 1993;22:512-9.
34. US Department of Agriculture, Agricultural Research Service. National nutrient database for standard reference. Available from: http://www.ars.usda. gov/nutrientdata (cited 10 January 2010).
35. de Groot E, van Leuven SI, Duivenvoorden R, et al. Measurement of carotid intima-media thickness to assess progression and regression of atherosclerosis. Nat Clin Pract Cardiovasc Med 2008;5:280-8.
36. Wang JG, Staessen JA, Li Y, et al. Carotid intima-media thickness and antihypertensive treatment: a meta-analysis of randomized controlled trials. Stroke 2006;37:1933-40.
37. Caslake MJ, Miles EA, Kofler BM, et al. Effect of sex and genotype on cardiovascular biomarker response to fish oils: the FINGEN Study. Am J Clin Nutr 2008;88:618-29.
38. Schaefer EJ, Bongard V, Beiser AS, et al. Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: the Framingham Heart Study. Arch Neurol 2006;63:1545-50.
39. Stein JH, Korcarz CE, Hurst RT, et al. Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force endorsed by the Society for Vascular Medicine. JAm Soc Echocardiogr 2008;21:93-111.
40. Polak JF, Person SD, Wei GS, et al. Segment-specific associations of carotid intima-media thickness with cardiovascular risk factors: the Coronary Artery Risk Development in Young Adults (CARDIA) study. Stroke 2010;41:9-15.
41. Malek AM, Alper SL, Izumo S. Hemodynamic shear stress and its role in atherosclerosis. JAMA 1999;282:2035-42.
42. Buil-Cosiales P, Irimia P, Berrade N, et al. Carotid intima-media thickness is inversely associated with olive oil consumption. Atherosclerosis 2008;196:742-8.
43. Saadatian-Elahi M, Slimani N, Chajès V, et al. Plasma phospholipid fatty acid profiles and their association with food intakes: results from a cross-sectional study within the European Prospective Investigation into Cancer and Nutrition. Am J Clin Nutr 2009;89:331-46.
44. Balk EM, Lichtenstein AH, Chung M, Kupelnick B, Chew P, Lau J. Effects of omega-3 fatty acids on coronary restenosis, intima-media thickness, and exercise tolerance: A systematic review. Atherosclerosis 2006;184:237-46. (Pubitemid 43049706)
45. Yokoyama M, Origasa H, Matsuzaki M, et al. Japan EPA lipid intervention study (JELIS) Investigators. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet 2007;369:1090-8 (Published erratum appears in Lancet 2007;370:220.)
46. Aranceta J, Pérez Rodrigo C, Naska A, Vadillo VR, Trichopoulou A. Nut consumption in Spain and other countries. Br J Nutr 2006;96:3S-11S (Erratum in: Br J Nutr 2008;99:447-8).
47. Ros E. Nuts and novel biomarkers of cardiovascular disease. Am J Clin Nutr 2009;89(suppl):1649S-56S.